Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Standard BioTools Inc LAB

Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.


NDAQ:LAB - Post by User

Comment by Humaniston Sep 30, 2020 9:59am
69 Views
Post# 31640988

RE:RE:fldm receives Add'l $22 M contract for covid testing expans.

RE:RE:fldm receives Add'l $22 M contract for covid testing expans.Hello personal, good to discuss this stock with  someone on the board, thx for responding. i am not aware of the production part of it, but i read somwhere about a month ago or approx 3 wks that they are already funded to develop commericalize the testing kits etc.

I agree with you that citron gave $20
gltarget, the stock hsould've popped more. however i think there are other tests on the makt in development and maybe thats one of the reasons that it was held down. unless it's being shorted  bc some people are trying to get in before the election. bc if the election goes democrate, the testing will be massive  and all effective testing companies will benefit.

however if it goes republican with present leader, testing will not be substantially increased.

my 2 cents
gl

<< Previous
Bullboard Posts
Next >>